Pico-Tesla Magnetic Therapies, LLC

Participate In Our Research


D. PARKINSON'S DISEASE PHASE III CLINICAL STUDY
Clearwater, Florida:

Research Study
This study is to see if the Resonator™ device is safe and can help to lessen the symptoms of Parkinson’s disease by putting out low strength magnetic fields around the body, as two smaller studies completed over the last two years suggest.

How Long Will the Study Last?
There are about 2 visits totaling about 2-1/2 hours to decide if you are able to take part in the study and to evaluate your Parkinson’s disease (PD) symptoms. If you qualify, you will get 24 procedures with the device, 3 times per week for 8 weeks with each visit lasting about 1-1/2 hours. Afterwards, there are 2 visits over one month to evaluate your PD symptoms. Each of these visits will take approximately one hour. If all procedures and test visits are completed, you will receive $750.

 

 

Please Download the latest version of Adobe Flash Player.

 

ABOUT US

Our Team

Participate in our research
News Releases

Terms & Conditions of Use

Click Here for FDA Approval Status
 
 
 
   
   

Where Do I Need to Go?
The exposures to the Resonator will take place at:
4700 140th Ave. North
Suite 101
Clearwater, Florida 33762
727-474-3722


View Larger Map

How Can I Take Part?
You may be eligible for the study if you have Parkinson’s disease, can move around and are between the ages of 30 to 85. Men and women are both eligible as well as any ethnicity. Some individuals with illnesses that cause Parkinson’s type symptoms or whose diagnosis of PD is not clear may not be eligible.

Where Can I Get More Information?
CALL: 727-474-3722
Pico-Tesla the Magneceutical® Company

NAME:
ADDRESS:
CITY:
STATE:
ZIPCODE:
PHONE:
EMAIL:

 
 

4700 140th Ave. N., Suite 101 • Clearwater, FL 33762 • 727-474-3722

HOME | CONTACT US

 
 

The Resonator™ device is an Investigational Device limited by Federal (or United States)
law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical®
Therapy generally available outside of Investigational Review Board (IRB) approved clinical studies.